
### [NCIT:C27880](http://purl.obolibrary.org/obo/NCIT_C27880)
**Label:** Intraurothelial Neoplasia

**Subclasses:** [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C37266](http://purl.obolibrary.org/obo/NCIT_C37266) (Bladder Flat Intraepithelial Lesion), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36286](http://purl.obolibrary.org/obo/NCIT_C36286) (Urinary System Finding) and [NCIT:C5035](http://purl.obolibrary.org/obo/NCIT_C5035) (Genitourinary Signs and Symptoms) 55.26%
- [NCIT:C100104](http://purl.obolibrary.org/obo/NCIT_C100104) (Sign or Symptom) and [NCIT:C36286](http://purl.obolibrary.org/obo/NCIT_C36286) (Urinary System Finding) 55.26%
- Thing 53.55%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 52.63%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 52.63%
- [NCIT:C36548](http://purl.obolibrary.org/obo/NCIT_C36548) (Loss of Chromosome 2q) 52.63%
- [NCIT:C36516](http://purl.obolibrary.org/obo/NCIT_C36516) (Loss of Chromosome 10q) 52.63%
- [NCIT:C36496](http://purl.obolibrary.org/obo/NCIT_C36496) (Loss of Chromosome 18q) 52.63%
- [NCIT:C36489](http://purl.obolibrary.org/obo/NCIT_C36489) (Gain of Chromosome 5p) 52.63%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 52.63%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 52.63%
- [NCIT:C3090](http://purl.obolibrary.org/obo/NCIT_C3090) (Hematuria) 52.63%
- [NCIT:C2999](http://purl.obolibrary.org/obo/NCIT_C2999) (Dysuria) 52.63%
- [NCIT:C27712](http://purl.obolibrary.org/obo/NCIT_C27712) (Loss of Chromosome 5q) 52.63%
- [NCIT:C26906](http://purl.obolibrary.org/obo/NCIT_C26906) (Urinary Frequency) 52.63%


